Is a coxsackievirus B5 antibody an immunoglobulin G (IgG) or immunoglobulin M (IgM) antibody, and can it indicate whether the infection is acute?

Coxsackievirus B5 Antibody Testing: IgG vs IgM and Acute Infection Assessment

Coxsackievirus B5 antibody testing can detect both IgM and IgG antibodies, with IgM indicating acute or recent infection and IgG indicating past infection or immunity—the presence of IgM antibody is the key marker for determining if an infection is acute.

Understanding the Antibody Types

When testing for coxsackievirus B5 (or any enterovirus), the test is not inherently "an IgG or IgM antibody"—rather, the laboratory assay can be configured to detect either or both immunoglobulin classes:

• IgM antibodies: Appear early in acute infection and indicate recent or current enterovirus infection 1, 2, 3
• IgG antibodies: Develop later and persist long-term, indicating past infection or immunity 1, 2, 3

This parallels the well-established serologic patterns seen with hepatitis A virus, where IgM confirms acute infection while IgG indicates past infection or immunity 4.

Determining Acuteness of Infection

The presence of enterovirus-specific IgM is the primary marker for acute infection. Research demonstrates that:

• IgM antibodies to coxsackievirus B5 were detected in 97% of patients with proven acute enterovirus infections 3
• IgM was present in 13 of 14 patients with paired sera showing recent enterovirus infection 1
• The sensitivity of IgM detection varies with timing: only 23% positive when serum collected within 3 days of symptom onset, but 83% positive when collected later 2

Practical Algorithm for Interpretation:

For acute infection diagnosis:

1. IgM positive = acute or recent infection (within weeks to months)
2. IgG positive alone = past infection or immunity
3. Both IgM and IgG positive = acute infection with developing immunity
4. Both negative = no evidence of infection (or too early in infection if <3 days from symptom onset)

Important Caveats and Pitfalls

Timing Matters

The sensitivity of IgM testing is significantly lower in the first 3 days after symptom onset 2. If clinical suspicion is high and initial IgM is negative, repeat testing 1-2 weeks later is warranted.

Cross-Reactivity Issues

• Coxsackievirus B5-based assays show broad reactivity across different enterovirus serotypes 1, 2
• False positives can occur with infectious mononucleosis and Mycoplasma pneumoniae infection 2
• Heterotypic reactions (cross-reactivity between different coxsackievirus types) occur in 0-15.6% of cases 5

Specificity Considerations

Among healthy controls, enterovirus IgM was absent in all tested individuals, while only 2 of 64 had IgA 1, indicating good specificity for acute infection when IgM is detected.

Clinical Application

For myocarditis specifically, coxsackievirus B IgM antibodies were detected in 69.6% of clinically diagnosed cases, with coxsackievirus B3 being most common, followed by B2, B4, B1, B5, and B6 6. This demonstrates the clinical utility of IgM testing for acute viral myocarditis diagnosis.

The key takeaway: Order both IgM and IgG testing when available—IgM positivity confirms acute infection, while the IgG response helps distinguish acute from past infection.